Shares of TG Therapeutics are set to resume trading at 2:20 p.m. ET, with quotation scheduled to resume at 2:15 p.m. ET, according to Nasdaq.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TGTX:
- TGTX Lands Huge Upswing on MS Drug Approval
- TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)
- TG Therapeutics receives FDA approval for Briumvi for relapsing MS
- Unusually active option classes on open December 27th
- TG Therapeutics call volume above normal and directionally bullish